Creatine, Honestly

July 2, 2026 16 min read The Human Machine

creatinesports-sciencesupplementsphosphocreatineexercise-physiologyevidence-based-medicinehuman-machine

Contents

Creatine has been studied in more controlled trials than almost any other sports supplement, and the accumulated evidence is unusually clean by the standards of nutrition science — which makes it worth separating from the noise around it. Some of that noise is outdated caution (the kidney-damage concern, which never had solid evidence behind it and has since been directly contradicted by long-term data). Some of it is marketing (buffered and hydrochloride forms claiming superiority they haven’t demonstrated in head-to-head trials). And some of it is genuine scientific nuance getting flattened into a headline, which is exactly what happened to the recent wave of “creatine boosts your brain” claims.

The useful frame for understanding creatine is not “supplement” but “battery capacity for a specific, fast-discharge energy system.” Your muscles run on ATP, but you store almost none of it — a resting muscle cell holds only a few seconds’ worth. Phosphocreatine is the buffer that keeps that ATP pool topped off during the first several seconds of maximal effort, and creatine supplementation is, mechanistically, an intervention that makes that buffer bigger. Everything else in this post — the loading phase debate, the strength effect sizes, the non-responder phenomenon, the cognitive claims — follows directly from that one mechanism, so that’s where to start.

The Phosphocreatine System: A Chemical Capacitor

Skeletal muscle draws on three energy systems, layered by how fast they can supply ATP and how long they can sustain that supply. The phosphocreatine (PCr) system is the fastest and shortest: it can regenerate ATP almost instantaneously, but the tank is small, and it’s essentially empty after 8 to 10 seconds of maximal effort. Glycolysis takes over next, supplying ATP more slowly but for longer, followed by oxidative phosphorylation, which is slow to spin up but can run for hours.

The chemistry of the PCr system is a single reversible reaction, catalyzed by the enzyme creatine kinase:

PCr + ADP + H+  <-->  ATP + Cr
        (creatine kinase)

When a muscle fiber fires and ATP gets hydrolyzed to ADP for energy, phosphocreatine immediately donates its phosphate group back to ADP, regenerating ATP in a single enzymatic step — far faster than glycolysis or the mitochondrial electron transport chain can respond. This is the biochemical equivalent of a capacitor sitting in parallel with a battery in a circuit: the battery (oxidative metabolism) supplies steady, sustained current, but a capacitor (phosphocreatine) can dump a large burst of charge instantly to cover a sudden spike in demand, buying time for the slower supply to ramp up.

     ENERGY SYSTEM CONTRIBUTION TO ATP SUPPLY DURING MAXIMAL EFFORT

  % contribution
       ^
  100% |PCr
       |\\\
       | \\\___
   75% |  \   \\___
       |   \      \\___              glycolytic
   50% |    \          \\___        //
       |     \             \\_____ //
   25% |      \                \\ //
       |       \                 X                    oxidative
    0% |________\_______________//\\__________________________
       +---------+---------+---------+---------+---------+------>
       0s       10s       30s       60s       2min      5min+

           capacitor          fast battery         slow battery
        (PCr, near-instant)  (glycolysis, ~30-90s)  (oxidative, sustained)

This is why creatine’s benefit shows up specifically in short, maximal, repeated efforts — a heavy set of 3 to 5 reps, a sprint, a jump, a set of cleans — and essentially disappears for steady-state endurance work where the phosphocreatine system was never the limiting factor to begin with. If your event lasts longer than about 10 seconds of continuous maximal output, you have already moved past the system creatine is expanding.

What Supplementation Actually Does: Loading the Buffer

A typical omnivorous diet, combined with endogenous synthesis in the liver, kidneys, and pancreas, keeps total body creatine stores around 120 grams for a 70 kg person, with roughly 95% of it sitting in skeletal muscle, split between free creatine and phosphocreatine. Muscle has a hard ceiling on how much creatine it can hold — roughly 160 mmol per kg of dry muscle — and most people, even before supplementing, are sitting at 60-80% of that ceiling. Supplementation’s entire mechanism of action is closing that gap: oral creatine monohydrate reliably increases intramuscular creatine and phosphocreatine content by 15-40%, which directly enlarges the capacitor described above and improves the muscle’s ability to shuttle high-energy phosphate between mitochondria and the contractile machinery via the creatine phosphate shuttle.

That is the entire mechanism. There is no separate “muscle-building” pathway — the downstream strength and hypertrophy effects (covered in the next section) are a consequence of being able to do more total high-quality work per training session, set after set, which compounds into better training adaptation over weeks. Creatine does not directly signal muscle protein synthesis; it lets you lift heavier and do more reps before the capacitor runs dry, and your body then adapts to that higher training stimulus the normal way.

Loading vs. Daily Dosing: Two Roads to the Same Saturation Point

The oldest practical debate in creatine use is whether you need a “loading phase.” Mechanistically, both approaches reach the same destination — full muscle saturation — they just take different roads:

Protocol	Dose	Time to saturation	Trade-off
Loading phase	20 g/day, split into 4 x 5 g doses	~5-7 days	Faster saturation; higher rate of GI discomfort and bloating at high single doses
Daily maintenance-only	3-5 g/day, single dose	~3-4 weeks	Slower saturation; better GI tolerance; no difference in eventual muscle creatine content

A loading phase raises intramuscular creatine roughly 20-40% faster than starting straight at a maintenance dose, but the ceiling reached is the same either way — the loading phase does not produce a higher final saturation, only a faster one. For someone with a competition or a training block starting in under two weeks, loading is a legitimate way to get the ergogenic effect online sooner. For anyone without that time pressure, skipping the loading phase and simply taking 3-5 g/day from day one reaches full effect within a month with less gastrointestinal downside. Once saturated, a simple 3-5 g/day maintenance dose is all that is needed indefinitely — there is no metabolic argument for cycling on and off, since creatine is not a hormone and does not downregulate any receptor or endogenous production pathway that requires a break to reset. Endogenous creatine synthesis does downregulate somewhat during supplementation, but it returns to baseline within weeks of stopping, with no rebound deficit.

The Actual Effect Sizes: What the Meta-Analyses Show

This is where creatine earns its “most-studied supplement” reputation — the strength and body-composition literature is large enough to support real meta-analytic pooling, and the numbers are consistent across independent analyses:

Outcome	Effect	Context
1RM / 3RM / 10RM strength gain	~20% improvement vs. ~12% for training alone	Combined with a resistance training program over 4-12 weeks
Strength effect size, moderate-to-high intensity training	SMD = 0.62	A 2025 meta-analysis subgroup stratified by training intensity
Fat-free mass gain (resistance-trained young men)	+3.39 kg vs. placebo	2026 meta-analysis, 37 RCTs, ages 18-30
Lean body mass gain (resistance-trained young men)	+2.70 kg vs. placebo	Same analysis
Effect without resistance training	Not significant	Same analysis — the training stimulus is the active ingredient; creatine amplifies it
General strength range across the literature	5-15% improvement	Broad summary range across the ISSN-reviewed literature, 4-12 week windows

The single most important row in that table is the one showing no significant effect without resistance training. Creatine is not a passive muscle-builder you take and wait — every well-controlled trial showing meaningful strength or lean-mass gains paired supplementation with a structured resistance training program. Taking creatine without training against the expanded energy capacity it provides is spending money to fill a tank you are not going to use.

Non-Responders: Why It Doesn’t Work the Same for Everyone

Not everyone who supplements gets a meaningful ergogenic effect, and the reason is now reasonably well characterized rather than mysterious. The strongest predictor is baseline muscle creatine content: people who start with lower intramuscular creatine stores have more room to fill and show the largest gains, while people who already sit close to the natural ceiling — often from a diet already rich in creatine, i.e., regular red meat and fish intake — have less headroom and show a blunted response. This is also the mechanistic reason vegetarians and vegans are consistently among the most reliable high-responders in the literature: a plant-based diet supplies essentially no dietary creatine, so baseline muscle stores tend to run lower, leaving more capacity for supplementation to fill.

Muscle fiber composition is a second, independent factor. Type II (fast-twitch) fibers rely more heavily on the phosphocreatine system for their explosive, short-duration contractions than Type I (slow-twitch) fibers do, and studies separating responders from non-responders have found a real compositional difference — responders averaging around 63% Type II fiber content versus roughly 40% in non-responders. Someone with a naturally fast-twitch-dominant fiber profile has more of exactly the tissue type creatine’s mechanism targets.

There is also a genetic component sitting underneath both of those factors: polymorphisms in the SLC6A8 gene, which codes for the creatine transporter responsible for actually moving creatine from blood into muscle cells, affect uptake efficiency independent of diet or fiber type. This is the same transporter gene implicated in a rare inherited creatine deficiency syndrome at its most severe end, and milder common variants likely explain some of the ordinary person-to-person variability in response that shows up even among people with similar diets and training backgrounds.

None of this means creatine “doesn’t work” for a given individual in principle — it means the ceiling they can reach through supplementation is closer to where they already are. A reasonable practical read: if you eat little to no red meat and have several years of consistent resistance training behind you, you are a strong candidate for a noticeable response. If you already eat creatine-rich foods daily and are relatively new to structured training, temper your expectations somewhat, though the training-stimulus effect described above will likely still dominate.

The Cognitive Claims, Examined Honestly

This is the part of the creatine conversation that most needs a careful read of the primary literature rather than the headline. A widely cited 2024 systematic review and meta-analysis pooled 16 RCTs across a wide age range and reported a positive overall effect of creatine supplementation on cognitive function, memory, and executive function. That is the number that gets repeated in most consumer coverage.

It is also a number that has been directly and specifically challenged on methodological grounds. When the European Food Safety Authority evaluated the same body of evidence for a formal health-claim assessment, it found that the meta-analysis had pooled results from multiple correlated cognitive subtests drawn from the same underlying studies as if they were independent data points — a statistical error that inflates the effective sample size and can manufacture significance that isn’t really there. A subsequent re-analysis using appropriate methods to account for that non-independence found the overall cognitive effect was no longer statistically significant, with one notable exception: a real, isolated benefit in older adults. EFSA’s formal conclusion was that no health claim about general cognitive enhancement could be supported by that evidence base. This is a textbook case of a genuinely interesting signal getting oversold by pooling methodology before the claim reached the public.

The evidence that does hold up under scrutiny is narrower and more specific: acute rescue of cognitive performance during sleep deprivation. A 2024 controlled study found that a single high dose of creatine measurably improved processing speed and short-term memory in sleep-deprived subjects, with effects beginning around 3 hours post-dose, peaking near 4 hours, and lasting up to 9 hours — a timeline that lines up with measurable changes in cerebral high-energy phosphate metabolites on imaging, giving the effect a plausible and directly observed mechanism rather than just a behavioral correlation. A follow-up study using a smaller per-kilogram dose replicated a milder version of the same effect on logical reasoning, language processing speed, and vigilance tasks under sleep deprivation.

The honest summary: the “creatine makes you smarter” framing that circulates in supplement marketing is not well supported once the pooling error in the flagship meta-analysis is corrected — general chronic cognitive enhancement in well-rested, healthy adults does not have solid legs to stand on outside of older adults, where a real if modest effect appears to hold. The narrower claim — that an acute creatine dose measurably blunts the cognitive penalty of sleep deprivation, with a mechanistic explanation on brain imaging to back it up — is a genuinely different and better-supported finding that gets uncritically merged into the broader claim far too often.

Kidney Safety: The Persistent Myth

The kidney-damage concern is the single most durable piece of creatine misinformation, and it has a clean, traceable origin: a small number of case reports — reviews of the safety literature point to as few as two — in which kidney problems were observed in people taking creatine, one of whom had a pre-existing kidney condition that was never adequately controlled for. That thin evidentiary base has nonetheless propagated for two decades.

The controlled evidence points the other way. A Cochrane Collaboration review pooling 12 RCTs found no significant adverse effects associated with creatine at recommended doses, and studies specifically tracking renal function have found no impact on glomerular filtration rate with short-term use and no impairment of kidney function with chronic supplementation tracked out to five years in healthy athletes. Expert consensus panels reviewing the full literature have concluded there is no evidence supporting a causal link between creatine supplementation and kidney disease in people with normal renal function to start with.

One genuinely useful piece of context, since it causes real confusion at annual physicals: creatinine — the standard marker on a basic metabolic panel used to estimate kidney function — is the breakdown product of creatine. Someone supplementing with creatine will show a mildly elevated serum creatinine on bloodwork as an expected, benign consequence of having more creatine in the system to break down, not as a sign of reduced kidney filtration. A physician unaware of the supplement history can misread this as a red flag. The practical takeaway is not that creatine is completely without any consideration — anyone with pre-existing kidney disease should still loop in their physician, out of ordinary caution around an already compromised system rather than because the evidence indicates new risk — but for people with normal kidney function, the “creatine wrecks your kidneys” claim does not survive contact with the actual long-term RCT and cohort data.

Forms: Monohydrate Remains the Reference Standard

The supplement aisle offers creatine monohydrate, hydrochloride (HCl), ethyl ester, and various “buffered” formulations (marketed under names like Kre-Alkalyn), each claiming an edge over plain monohydrate:

Form	Claimed advantage	What the evidence actually shows
Monohydrate	None claimed — it’s the baseline	Most extensively studied form by a wide margin; cheapest; the reference standard every other form is measured against
Hydrochloride (HCl)	Higher solubility, smaller effective dose	Some evidence of modestly higher relative bioavailability; head-to-head trials show similar strength and body-composition outcomes to monohydrate at matched intake — the solubility difference has not translated into a demonstrated performance edge
Ethyl ester	Better absorption	Evidence points the opposite direction — ethyl ester converts to creatinine faster in solution and the gut, meaning less intact creatine may actually reach muscle tissue than with monohydrate
Buffered (e.g., Kre-Alkalyn)	Reduced degradation to creatinine, less bloating	Marketing claims not supported by independent head-to-head trials against monohydrate at equal doses

None of the alternative forms have produced a controlled trial showing a meaningfully better outcome than monohydrate at an equivalent dose. Given that monohydrate also has the deepest safety record and the lowest price per effective gram, it remains the rational default; paying a premium for an alternative form is a bet against a large body of comparative evidence, not a hedge in favor of one.

A Practical Protocol

Distilling the above into something usable:

Dose: 3-5 g/day of creatine monohydrate, taken daily and indefinitely. No cycling required.
Loading: Optional. Use 20 g/day split into four 5 g doses for 5-7 days only if you have a specific reason to reach saturation faster than the 3-4 weeks a straight maintenance dose takes.
Timing: Largely irrelevant to long-term saturation; some trial evidence weakly favors taking it near a resistance training session (post-workout slightly outperformed pre-workout timing in one controlled comparison), but the effect size of timing itself is small relative to consistency of daily intake.
With food: Taking it alongside a meal, particularly one with carbohydrate and protein, may modestly improve muscle uptake via the associated insulin response, though this is a secondary optimization, not a requirement.
Hydration: No controlled evidence supports the old claim that creatine requires materially increased water intake beyond normal training hydration needs, though adequate hydration is sound general advice regardless.
Pairing: The ergogenic effect is contingent on a structured resistance (or explosive/sprint) training program. Without that training stimulus, expect the body-composition and strength literature above to simply not apply to you.

Verdict

Creatine monohydrate is one of the few supplements where the mechanism, the effect size, and the safety profile all line up cleanly with the marketing claim — a rare occurrence in this category. The phosphocreatine system is a well-characterized, fast-discharge energy buffer, supplementation reliably expands that buffer by 15-40%, and that expansion translates into measurable strength and lean-mass gains specifically when paired with resistance training, in the range of a genuine 20% versus 12% improvement over training alone. Loading is a convenience option, not a requirement. The kidney-safety fear does not hold up against the long-term controlled data. And the cognitive story is real but narrower than the headlines: a solid, mechanistically grounded acute benefit during sleep deprivation, and a much shakier general “smarter for everyone” claim that a formal regulatory review found rested on a statistical error in the pooling method.

The honest bottom line: if you resistance train regularly, 3-5 g/day of plain creatine monohydrate is one of the best-evidenced, cheapest performance interventions available, and the loading phase, exotic forms, and cycling protocols surrounding it are mostly unnecessary complexity layered on top of a simple, well-understood mechanism.